Nykode Therapeutics AS (OTCMKTS:VACBF) Stock Short Interest Jumps 67.6%

Nykode Therapeutics AS (OTCMKTS:VACBF) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 2,480 shares, a growth of 67.6% from the August 31st total of 1,480 shares. Based on an average daily volume of 600 shares, the short-interest ratio is currently 4.1 days.

Nykode Therapeutics AS Price Performance

OTCMKTS:VACBF opened at $0.45 on Friday. The stock’s fifty day moving average price is $0.38 and its two-hundred day moving average price is $0.37. Nykode Therapeutics AS has a 52-week low of $0.32 and a 52-week high of $0.45.

Nykode Therapeutics AS Company Profile

Nykode Therapeutics AS is a Norwegian biotechnology company focused on developing targeted immunotherapies for cancer and autoimmune diseases. The company’s approach is designed to direct therapeutic payloads to specific immune cells, with the goal of generating targeted and durable immune responses.

Nykode’s technology platform, originally developed under the Vaccibody name, uses modular molecules that can target antigens to antigen-presenting cells and stimulate both cellular and antibody-based immunity.